Evidence snapshot: The strongest available evidence is a small Phase 1 human trial (Teichman et al., 2006) showing dose-dependent, sustained elevation of GH and IGF-1 in healthy adults
788 One study of nearly 2 million beneficiaries of traditional Medicare living with dementia found that PCPs were the clinician type seen by the largest percentage of those beneficiaries in the study year (2019): 87.0% of beneficiaries received care from a physician, 62.9% from a nurse practitioner and 33.1% from a physician assistant
[DOI] [PMC free article] [PubMed] [Google Scholar] 379
This usually comes down to: Labeling differences Intended use (research vs clinical) Regulatory positioning For example: Bacteriostatic Water is commonly associated with medical labeling Reconstitution Solution is often used in research or laboratory contexts Same concept, different positioning
Running a 3mg daily protocol for 33 days uses everything vs
Despite a potential sacrifice in bioavailability over injections, some researchers may wish to use a BPC-157 + TB-500 nasal spray to study the effects of concurrent administration